ArticleBMC gastroenterology2025

BIGH3 as a potential biomarker for fibrosis in metabolic dysfunction-associated steatotic liver disease: insights from mouse and human studies.

Zhenjie Zhuang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.